No title
Targeting neuroinflammation, a key factor in the progression of chronic neurological disorders such as Alzheimer’s disease and epilepsy, is essential for discovering effective treatments. Recent studies indicate that Pannexin-1 (Panx-1) channels serve as the primary pathways for ATP release from degenerating and innate immune cells in the brain, triggering neuroinflammation. By blocking it with a
